Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NeuroVive Pharmaceutical AB Interim Report January - September 2019

Continued progress in KL1333.Important events July – September · NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study · NeuroSTAT receives Fast Track designation from the US Food and Drug Administration. Financial information third quarter (July-September 2019) · Net revenues: KSEK 0 (0) · Other operating income: KSEK 1,500 (0) · Loss before tax: KSEK -15,297 (-14,982) · Loss per share*: SEK -0.08 (-0.20) · Diluted loss per share**: SEK -0.08 (-0.20) Financial information first nine months (January-September 2019) · Net revenues:

High Performance, biggest order so far from China

Nexam Chemical has received an order from China of approximately SEK 1.3 million in the High Performance segment. The order comes from Nexam Chemical's distributor in China and is the result of successful collaboration with the customer during the year. The product to which the order applies is used in the segment of high temperature composites and will be resold to a number of customers in the country.“We see China as an increasingly important market for us. For a long time the country was an area where we only purchased raw materials, but over the last 2 years this has changed at a rapid

Biovica’s DiviTum – Strong prognostic marker in operable breast cancer

Uppsala, Sweden, November 20, 2019. Biovica, active in cancer biomarkers, today announced clinical data that demonstrate DiviTum as a strong prognostic marker in operable breast cancer. The results will be presented at the San Antonio Breast Cancer Symposium, SABCS, December 10-14, 2019, the world´s largest scientific congress focusing on breast cancer.The study is a retrospective analysis on serum samples from a randomized clinical trial comprising 644 women with operable breast cancer (premenopausal with stage II-IIIB HR+ breast cancer). Serum samples were collected pre-operatively on the

Interim update

Considering the current pipeline of activities, the Company expects that it will be able to register revenue growth (year-on-year) in the second half of the year. Advanced discussions proceed with existing and prospective customers in North America, Europe, China and many other parts of the world. Significant investments are made to further develop the organisation, strengthen sales and support, and expand the product portfolio with special attention paid to cloud-computing, open interfaces and close integration into network management systems.For further information, please contact: Per

Redeye initiates coverage of I-Tech

Redeye initiates coverage of I-Tech, a provider of a unique antifouling ingredient, used in marine paint. We see an attractive envirotech case with rapid growth and operational leverage, derived from a strong value proposition and key market drivers. Our valuation offers upside potential, supported by several catalysts which may improve the investor sentiment. Read more and download the research update: http://bit.ly/2KzEiRy Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research

Flexion Mobile Plc - Q2 Report 30 September 2019

Flexion continues its steady growth in the second financial quarter with total quarterly revenue increasing by 46% to GBP 2.3m compared to the same period in the previous year. This represents a quarter-on-quarter growth of 20% and a 38% growth in the last six months. During the quarter, the Company launched its second biggest top-tier title, signed a new mid-tier title and announced a new partnership with Xiaomi.July 2019 to September 2019 performance · Total revenue increased by 46% to GBP 2.3m (GBP 1.6m)* · Gross profit increased by 8% to GBP 0.3m (GBP 0.3m) · Adjusted EBITDA

Biovica’s DiviTum validated as a dynamic biomarker in metastatic breast cancer in collaboration with Institut Curie, Paris

Uppsala, Sweden, November 20, 2019. Biovica, active in cancer biomarkers, today announced that clinical data – demonstrating that DiviTum can be used as a dynamic, non-invasive biomarker for metastatic breast cancer patients treated with endocrine therapy and palbociclib – will be presented at the San Antonio Breast Cancer Symposium, December 10-14, 2019, the world´s largest scientific congress focusing on breast cancer.The prognostic value of DiviTum was assessed in a prospective study of 103 metastatic breast cancer patients treated from May 2016 until August 2018 at Institut Curie, Paris,

Comment regarding information in Uppdrag granskning

Today, Swedish Public Service (SVT) news programme Uppdrag granskning published an episode containing information that Swedbank may have violated US sanction regulation.“It is a good thing that the bank is being investigated and I welcome Uppdrag granskning’s reporting”, says Jens Henriksson, President and CEO of Swedbank. During an interview SVT made on November 7, the bank received a document, which was handed over to Swedbank’s internal investigation headed by the international law firm Clifford Chance. According to Clifford Chance, information in the document was, if relevant to

Asarina Pharma AB (publ) Interim Report Q3 2019 released

Asarina Pharma CEO Peter Nordkild: “During an intense third quarter we achieved some important milestones. We enrolled the last patient in our landmark PMDD study, received FDA approval for our IND in menstrual migraine and included the first patient in our menstrual migraine study. After the end of the quarter a new directed share issue was subscribed to by a small group of distinguished institutional investors, generating net proceeds of SEK 44.5 million.”FINANCIAL HIGHLIGHTS 1 July – 30 September 2019 · Due to increased R&D activities, operating costs grew to SEK 21.8 million ·

Interim report January-September 2019

STRONG GROWTH IN THE THIRD QUARTERThird quarter 2019 (third quarter 2018) · Net sales amounted to SEK 40.4 million (32.7), equivalent to a growth of 23.6 percent compared to the corresponding period in the previous year. · EBITDA amounted to SEK 2.2 million (-2.3). · The EBITDA margin amounted to 5.4 percent (-7.1). · Operating profit (EBIT) amounted to SEK -0.8 million (-3.0). · The EBIT margin amounted to -2.0 percent (-9.2). · Profit before taxes amounted to -1.3 million (-3.3). · Cash flow amounted to SEK 3.2 million (-1.6). · The average number of employees

Clavister Q3 2019: Positive Adjusted EBITDA

November 20, 2019. Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its latest quarterly report today. “We are pleased to report positive EBITDA in the third quarter of 2019, before adjustments related to the divestment of our Chinese subsidiary. We continue to see a strong momentum in our focused go-to-market activities, with a year-on-year order intake growth of 24%. The largest growth for the quarter, 158% year-on-year, came from the Communication Service Provider vertical. My assessment is that we are advancing into larger business

Redeye: Better Collective - Favorable odds

Better Collective´s third quarter was another ATH quarter, with a Y/Y growth of 54% and organic growth of 25%. However, both revenues and profit margins came in below our estimates. Nevertheless, the outlook is impressive, and Better Collective continues to deliver on its acquisition strategy. We expect that the US market will become a major growth driver and that Better Collective´s profitable growth story will continue. We have updated our estimates and increased the fair value to SEK 100 (98) per share in Base case. Read more and download the research update: http://bit.ly/2rWyR8J

Interim report for the period from 1 january to 30 september 2019

Zengun Group AB started its operations on 24 May 2019 when the company acquired all of the shares in Zengun Group Holding AB (Corp. Reg. No. 559050-0699) and its wholly owned subsidiaries from Segulah Fund V. Financial information for the former group (Zengun Group Holding AB) has been included as a basis for comparison.ZENGUN Group AB (publ)Third quarter• Net turnover amounted to MSEK 561.0.• EBITDA totalled MSEK 25.4. 24 May 2019 – 30 September 2019• Net turnover amounted to MSEK 764.4.• EBITDA totalled MSEK 32.9.• Operating cash flow was negative MSEK 21.8. ZENGUN Group

Panoro Energy Announces Third Quarter 2019 Results and Provides Operations and Corporate Updates

Oslo, 20 November 2019 - Panoro Energy (the “Company” or “Panoro” with OSE ticker: “PEN”) today announces the third quarter 2019 financial results and subsequent events.  John Hamilton, CEO of Panoro, commented: “Our transformation into a well-balanced and diversified E&P company is reflected in our strong financials year to date. Full year results will strengthen this trend with a particularly active 4th quarter lifting schedule anticipated. Dussafu Phase 2 production drilling is underway with the next step up in production occurring during the first half of 2020. The sizeable

Co-operation negotiations in Glaston's Finnish units have ended

Glaston Corporation   Other information disclosed according to the rules of the Exchange    20 November 2019  8.30 amGlaston’s co-operation negotiations concerning adaptation measures have ended. As a result, Glaston plans to decrease the number of employees in Finland by approximately 12 people, out of which at most 8 employments will be terminated. Previously Glaston had estimated that the negotiations could lead to the termination of approximately 20 employments. In addition, the Finnish operations are planned to be adapted to the decrease in the order book for heat treatment machines

Flex LNG – Q3 2019 Presentation

Flex LNG – Q3 2019 Presentation Please find enclosed the presentation of Flex LNG Ltd.’s third quarter 2019 results to be held on the webcast/conference call 20 November, 2019 at 3:00 p.m. CET (9:00 a.m. ET). Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/hhpedipx Attend by Conference Call: Applicable dial-in telephone numbers are as follows: Norway: +47 21 56 31 62 United Kingdom:+44 (0) 203 0095710 United Kingdom, local: 08444933857 United States: +1 917-720-0178 United States (toll free): +1 866 869 2321 Confirmation Code:

Flex LNG Q3, 2019 Earnings Release

November 20, 2019 – Hamilton, BermudaFlex LNG Ltd. (“Flex LNG” or the “Company”) today announced its unaudited financial results for the third quarter and nine months ended September 30, 2019.  Highlights: · Reported revenues of $29.8 million for the third quarter 2019, compared to $19.0 million for the second quarter 2019. · Average Time Charter Equivalent (“TCE”) rate of $58,222 per day for the third quarter 2019, compared to $46,266 per day for the second quarter 2019. · Adjusted EBITDA of $21.8 million for the third quarter 2019, compared with $11.3 million for the

Magnus Törnblom new Director of Press Relations at Axfood

Axfood has appointed Magnus Törnblom as its new Director of Press Relations. He has most recently served as Head of Press at Klarna Bank, and prior to that as Head of Corporate Press & Communications at Bonnier Broadcasting and TV4-Gruppen.Magnus Törnblom has a long and extensive record of experience with press and communication matters, serving most recently at Klarna Bank. Prior to this he worked for Bonnier Broadcasting and TV4-Gruppen for more than ten years, ending as Head of Corporate Press & Communications. “I am very eager to work together with Magnus on developing Axfood’s

Change in HKScan’s Group Management Team

HKScan Corporation, Stock Exchange Release, 20 November 2019, at 8:00 (EET)Change in HKScan’s Group Management Team Sofia Hyléen Toresson, EVP for HKScan’s Swedish market area and a Group Management Team member, has decided to leave her position at the company. Denis Mattsson has been appointed HKScan’s interim EVP for the market area Sweden and a member of the Group Management Team as of 20 November 2019. Denis Mattsson has extensive international expertise in leading positions in the food industry, especially in the meat sector. Between 2006 and 2012, Mattsson worked as EVP for

Vattenfall and Microsoft pilot world’s first h ourly matching (24/7) of renewable energy

Vattenfall and Microsoft have jointly developed a first-of-its-kind solution, providing customers a new level of transparency into their electricity consumption making it possible to go from year-based data to hourly based data on source of origin. The solution, 24/7 Matching, is being piloted at Vattenfall and Microsoft Headquarters in Sweden.The new 24/7 solution is built with Microsoft Azure IoT Central platform that connects energy generation such as wind- and hydro power from Vattenfall, with data from smart meters that measure the consumption in real-time. “We are very happy to

Webstep ASA: Application of shares by primary insiders

Oslo, 20 November 2019. Reference is made to the stock exchange announcement by Webstep ASA ("Webstep") on 19 November 2019 regarding the offer of shares to employees (the "Offer").The application period in the Offer commenced on 19 November 2019. As of today, 20 November 2019, the following primary insiders have applied for shares in the Offer:  - Arne Lee Norheim (CEO), for an amount of NOK 15,000 (excluding the discount given in the Offer); - Liv Annike Kverneland (CFO), for an amount of NOK 15,000 (excluding the discount given in the Offer); - Rolf Helle (Director Business

QuickCool AB (publ) signs letter of intent with Biovation

As previously communicated, QuickCool AB (publ) (“QuickCool”) proposes to transform the existing QuickCool company into a holding structure to invest in cannabis and other alternative medical markets as well as to, in a separate new subsidiary, continue to develop QuickCool® SYSTEM.As part of the change of business, QuickCool intends to enter an agreement with Biovation Sciences Ltd. (“Biovation”) regarding investment advice and support for investments in additional operations. As of 19 November 2019, QuickCool and Biovation have entered into a letter of intent on such collaboration.

EAB GROUP PLC: ACQUISITION OF OWN SHARES 19.11.2019

EAB GROUP PLC NOTIFICATION 19.11.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 19.11.2019   Date 19.11.2019  Exchange transaction Buy  Share class EAB  Amount 410  Average price/share 2.6952 EURHighest price/share 2.7000 EURLowest price/share 2.6800 EURTotal price 1,105.03 EUR      The shares held by EAB Group Plc on 19.11.2019:   EAB 4,173     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.11.2019

Fiskars Corporation  NOTIFICATION 19.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.11.2019 Date 19.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.9150 EUR  Highest price/share 11.9400 EUR Lowest price/share 11.9000 EUR Total price  11,915.00 EUR  The shares held by Fiskars Corporation on 19.11.2019: FSKRS 383,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

There are no items matching the current filter
There are no more items matching the current filter
Back to top